APGE vs SRPT · $2.34B cap vs rev $1.13B
Apogee Therapeutics, Inc. Common Stock (APGE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
APGE currently screens at market cap $2.34B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the APGE and SRPT stock pages for the full models.
Not investment advice.